Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0HC9U
|
||||
Former ID |
DNC010871
|
||||
Drug Name |
4-Imidazol-1-ylmethyl-2-nitroxanthen-9-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551345] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H11N3O4
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=O)C3=CC(=CC(=C3O2)CN4C=CN=C4)[N+](=O)[<br />O-]
|
||||
InChI |
1S/C17H11N3O4/c21-16-13-3-1-2-4-15(13)24-17-11(9-19-6-5-18-10-19)7-12(20(22)23)8-14(16)17/h1-8,10H,9H2
|
||||
InChIKey |
FTWURRJWFIOKBA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [551345] | |
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | Endogenous sterols | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.